From Volume 48, Issue 3, March 2021 | Pages 186-190
Ameloblastoma is a benign and locally aggressive neoplasm. The treatment of choice is surgical resection, which, although removing tumour, will often result in aesthetic and functional problems for the patient.
CPD/Clinical Relevance: For patients with ameloblastoma in the maxilla, careful planning with the involvement of a multidisciplinary team is essential for improving post-surgical quality of life.
Ameloblastoma is a benign and locally aggressive neoplasm. It is the most common neoplasm of origin from the odontogenic epithelium and may arise from the enamel organ, epithelium of odontogenic cysts or basal cells of the oral mucosa.1 In most cases, ameloblastomata arise in the mandibular molar and ramus regions;1 however, they may also arise in the maxilla. This case report describes the prosthodontic pathways in the interdisciplinary management of a patient who was diagnosed with a solid unicystic ameloblastoma in the maxilla, and who underwent maxillectomy.
A 17-year-old male patient who was waiting for partial maxillectomy as the necessary treatment for an ameloblastoma, presented to the Restorative Unit at the Dental Institute, Colombo after being referred from the Oral and Maxillofacial Surgery Unit of the same institute. The oral and maxillofacial surgeon's main concern was the construction of a surgical obturator prior to the surgical excision of the tumour.
Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:
What's included
